Health and Healthcare

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

252 Articles

Chris Lange | Sep 2, 2016 at 7:40 AM EDT

8 Major FDA Decisions and Trial Results to Watch for in September

24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in September.

Chris Lange | Jul 12, 2016 at 10:10 AM EDT

Biotechs With Drug Pipelines Closest to Zero Valuation

Credit Suisse has taken a look at which biotech companies in its coverage have the least credit given to pipeline…

Jon C. Ogg | Jun 28, 2016 at 12:01 PM EDT

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

[cnxvideo id=”655353″ placement=”ros”]Sometimes market volatility and outside shocks create a rift between market prices and real value. That may currently…

Chris Lange | May 25, 2016 at 9:40 AM EDT

5 Major Clinical Trial Results Coming Up

24/7 Wall St. has collected several big FDA decisions and imminent clinical trial results that should be coming up in…

Chris Lange | May 1, 2016 at 10:15 AM EDT

How Analysts View Vertex After Earnings

One portfolio manager on CNBC noted that Vertex could end up being an acquisition target ahead, without mentioning any specifics.

Jon C. Ogg | Apr 28, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Facebook, First Solar, Hess, Texas Instruments, US Steel, Vertex, Infinera and More

The top analyst upgrades, downgrades and initiations seen on Thursday morning include Facebook, First Solar, Hess, Texas Instruments, U.S. Steel,…

Lee Jackson | Apr 12, 2016 at 8:25 AM EDT

Top Biotech Picks Highlight Jefferies Growth Stocks to Buy

A new Jefferies research report highlights their top growth picks for this week, and the list is dominated by top…

Lee Jackson | Apr 7, 2016 at 10:10 AM EDT

3 Hot Growth Stocks With Upside Potential That May Not Be Appreciated by Wall Street

Sometimes after a stock has a good run, the analysts on Wall Street start to get a little gun-shy, especially…

Chris Lange | Apr 6, 2016 at 10:05 AM EDT

5 Biotechs With the Most Upside This Earnings Cycle

Despite a modest erosion to fundamentals and sector headwinds, Jefferies does not anticipate any dramatic earnings misses, which could help…

Chris Lange | Mar 29, 2016 at 9:35 AM EDT

8 Major Biopharma Events Coming Later in 2016 and in 2017

FDA rulings can make or break some companies. 24/7 Wall St. has collected eight key FDA decisions coming up in…

Chris Lange | Mar 23, 2016 at 11:15 AM EDT

Jefferies Identifies 5 Top Biotech Stocks for Huge Upside

Jefferies believes most of the significant biotech downside already occurred, though volatility could continue in the near term.

Jon C. Ogg | Feb 1, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Chipotle, Cisco, Micron, Seagate, Vertex, Disney, Xerox and Many More

Monday's top analyst calls include Chipotle Mexican Grill, Cisco Systems, Micron Technology, Seagate Technology, VertexPharmaceuticals, Walt Disney and Xerox.

Chris Lange | Jan 31, 2016 at 10:20 AM EST

3 Key FDA Decisions Expected in February

24/7 Wall St. has collected three big FDA decisions coming up in February and added some color, along with the…

Chris Lange | Jan 20, 2016 at 11:45 AM EST

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. It initiated several top biotech stocks…

Jon C. Ogg | Oct 2, 2015 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: AIG, Facebook, Gilead, Google, Regeneron, Twitter, Valeant, Vertex and More

Friday’s top analyst upgrades, downgrades and initiations include AIG, Facebook, Gilead Sciences, Google, Regeneron Pharmaceuticals, Twitter, Valeant Pharmaceuticals and Vertex…

1 … 7 8 9 10 11 … 17

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

8 Major FDA Decisions and Trial Results to Watch for in September

Biotechs With Drug Pipelines Closest to Zero Valuation

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

5 Major Clinical Trial Results Coming Up

How Analysts View Vertex After Earnings

Top Analyst Upgrades and Downgrades: Facebook, First Solar, Hess, Texas Instruments, US Steel, Vertex, Infinera and More

Top Biotech Picks Highlight Jefferies Growth Stocks to Buy

3 Hot Growth Stocks With Upside Potential That May Not Be Appreciated by Wall Street

5 Biotechs With the Most Upside This Earnings Cycle

8 Major Biopharma Events Coming Later in 2016 and in 2017

Jefferies Identifies 5 Top Biotech Stocks for Huge Upside

Top Analyst Upgrades and Downgrades: Chipotle, Cisco, Micron, Seagate, Vertex, Disney, Xerox and Many More

3 Key FDA Decisions Expected in February

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Top Analyst Upgrades and Downgrades: AIG, Facebook, Gilead, Google, Regeneron, Twitter, Valeant, Vertex and More

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

8 Major FDA Decisions and Trial Results to Watch for in September

Biotechs With Drug Pipelines Closest to Zero Valuation

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

5 Major Clinical Trial Results Coming Up

How Analysts View Vertex After Earnings

Top Analyst Upgrades and Downgrades: Facebook, First Solar, Hess, Texas Instruments, US Steel, Vertex, Infinera and More

Top Biotech Picks Highlight Jefferies Growth Stocks to Buy

3 Hot Growth Stocks With Upside Potential That May Not Be Appreciated by Wall Street

5 Biotechs With the Most Upside This Earnings Cycle

8 Major Biopharma Events Coming Later in 2016 and in 2017

Jefferies Identifies 5 Top Biotech Stocks for Huge Upside

Top Analyst Upgrades and Downgrades: Chipotle, Cisco, Micron, Seagate, Vertex, Disney, Xerox and Many More

3 Key FDA Decisions Expected in February

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Top Analyst Upgrades and Downgrades: AIG, Facebook, Gilead, Google, Regeneron, Twitter, Valeant, Vertex and More

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation